Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · Real-Time Price · USD
26.80
-2.42 (-8.28%)
At close: Nov 16, 2026, 4:00 PM EST
26.90
+0.10 (0.37%)
After-hours: Nov 16, 2026, 4:06 PM EST

Viking Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
677.61165.8126.6855.5236.6326.37
Short-Term Investments
282.2539.93875.94306.56118.85175.73
Cash & Short-Term Investments
959.81705.74902.61362.08155.49202.1
Cash Growth
34.32%-21.81%149.29%132.87%-23.07%-18.63%
Prepaid Expenses
3.181.811.132.523.410.62
Other Current Assets
10.018.053.482.628.147.81
Total Current Assets
973715.6907.22367.23167.04210.53
Property, Plant & Equipment
3.850.0911.131.420.03
Long-Term Deferred Charges
--0.060.110.040.08
Other Long-Term Assets
0.320.050.050.030.030.03
Total Assets
977.17715.73908.32368.49168.53210.66

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
82.1353.259.817.518.531.44
Accrued Expenses
51.7423.2817.1111.313.117.31
Current Portion of Leases
0.020.140.490.320.30.03
Total Current Liabilities
133.976.6727.4119.1421.958.78
Long-Term Debt
250.66-----
Long-Term Leases
4.01-0.630.941.26-
Total Liabilities
388.5776.6728.0420.0723.218.78

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
000000
Additional Paid-In Capital
1,9071,4861,369733.55445.27425.61
Retained Earnings
-1,317-847.55-487.91-377.94-292.05-223.18
Treasury Stock
----6.8-6.8-
Comprehensive Income & Other
-1.70.38-0.79-0.39-1.1-0.55
Shareholders' Equity
588.6639.06880.28348.42145.32201.88
Total Liabilities & Equity
977.17715.73908.32368.49168.53210.66

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
254.690.141.121.261.560.03
Net Cash (Debt)
705.12705.6901.49360.82153.92202.07
Net Cash Growth
-1.22%-21.73%149.85%134.42%-23.83%-18.53%
Net Cash Per Share
6.086.268.273.822.002.62
Filing Date Shares Outstanding
127.52115.55112.25100.4978.4278.36
Total Common Shares Outstanding
127.52114.79111.57100.1178.2678.25
Working Capital
839.1638.93879.8348.09145.09201.75
Book Value Per Share
4.625.577.893.481.862.58
Tangible Book Value
588.6639.06880.28348.42145.32201.88
Tangible Book Value Per Share
4.625.577.893.481.862.58
SEC Filings: 10-K · 10-Q